Q-linea AB (FRA:3F80) Other Current Liabilities: kr0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3F80 Q-linea AB FRA:3F80
65 GF Score
Price kr1.49
GF Value kr1.72
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Other Current Liabilities?

Q-linea AB FRA:3F80 65 Other Current Liabilities is kr0.00 Mil as of Jun. 2026. GuruFocus rates FRA:3F80 with a GF Score™ of 65/100 and a GF Value™ of kr1.72. The stock has 3 warning signs investors should review.

Q-linea AB's other current liabilities for the quarter that ended in Jun. 2026 was kr0.00 Mil.

Q-linea AB's quarterly other current liabilities declined from Dec. 2025 (kr21.61 Mil) to Mar. 2026 (kr17.65 Mil) and declined from Mar. 2026 (kr17.65 Mil) to Jun. 2026 (kr0.00 Mil).

Q-linea AB's annual other current liabilities increased from Dec. 2023 (kr16.47 Mil) to Dec. 2024 (kr17.47 Mil) and increased from Dec. 2024 (kr17.47 Mil) to Dec. 2025 (kr21.61 Mil).

Q-linea AB Other Current Liabilities Related Terms

Q-linea AB Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Q-linea AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-linea AB Other Current Liabilities Chart

Q-linea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.43 24.24 16.47 17.47 21.61

Q-linea AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.85 15.26 21.61 17.65 0.00
FRA:3F80
65GF Score
Q-linea AB FRA:3F80
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-linea AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of kr0.00 Mil mean?
Q-linea AB (FRA:3F80) has a Other Current Liabilities of kr0.00 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Q-linea AB.
Is Q-linea AB's Other Current Liabilities too high?
Q-linea AB's current Other Current Liabilities is kr0.00 Mil. Overall, Q-linea AB has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Other Current Liabilities compare to ABT and SYK?
Q-linea AB's Other Current Liabilities of kr0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Q-linea AB. Q-linea AB's current Other Current Liabilities is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Q-linea AB (FRA:3F80) has a current Other Current Liabilities of kr0.00 Mil. The stock's GF Value™ is kr1.72, compared to a current price of kr1.49 — trading 13.4% below its estimated fair value. The current Other Current Liabilities is kr0.00 Mil. Q-linea AB's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Q-linea AB (FRA:3F80), the current Other Current Liabilities is kr0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Q-linea AB (FRA:3F80) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued. The current stock price of kr1.49 is trading 13.4% below its estimated GF Value™ of kr1.72.

Key valuation signals for FRA:3F80:

  • Other Current Liabilities: kr0.00 Mil
  • GF Value™: kr1.72 vs. price of kr1.49 (13.4% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the FRA:3F80 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Q-linea AB Business Description

Other Exchanges QLINEA:Sweden
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
65GF Score

Get the complete analysis for FRA:3F80

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.49
Price
kr1.72
GF Value